Treatment SS levels | Cv. Giza 843 | Cv. Sakha 1 | Cv. 716 | |||||||||
F. m. | % | D. M. | % | F. M. | % | D. m. | % | F. m. | % | D. m. | % | |
C | 4.9 | 100 | 0.856 | 100 | 4.49 | 100 | 1.56 | 100 | 15.1 | 100 | 2.9 | 100 |
20% | 6.0 | 147.6 | 1.20 | 140.2 | 6.51 | 144.9 | 2.03 | 130.1 | 11.6 | 76.8 | 2.0 | 68.9 |
50% | 8.7 | 177.8 | 1.98 | 231.3 | 6.59 | 146.8 | 2.51 | 160.9 | 5.9 | 39.1 | 1.1 | 37.9 |
70% | 10.4 | 211.2 | 2.6 | 3.1.4 | 8.08 | 179.9 | 3.11 | 199.3 | 4.7 | 31.1 | 1.5 | 51.7 |
100% | 9.92 | 202 | 2.2 | 252.3 | 2.27 | 50.7 | 0.33 | 21.1 | 4.5 | 29.8 | 0.95 | 32.7 |
C + IAA | 7.54 | 153.6 | 1.5 | 171.7 | 13.7 | 305.1 | 2.78 | 187.9 | 6.9 | 45.7 | 1.3 | 44.8 |
20% + IAA | 9.08 | 148.9 | 2.1 | 248.8 | 10.3 | 229.4 | 3.21 | 115.4 | 6.7 | 44.4 | 1.7 | 58.6 |
50% + IAA | 11.8 | 241.9 | 2.7 | 320 | 12.7 | 282.8 | 4.82 | 308.9 | 8.6 | 56.9 | 1.5 | 51.2 |
70% + IAA | 10.7 | 2 18.4 | 2.8 | 327.1 | 11.5 | 256.1 | 3.11 | 199.3 | 9.8 | 64.9 | 1.8 | 62.1 |
100% + IAA | 10.4 | 211.8 | 2.2 | 257.0 | 10.4 | 231.6 | 1.40 | 89.7 | 9.77 | 64.7 | 1.9 | 65.5 |
C + SA | 13.8 | 281 | 2.98 | 348.1 | 6.5 | 144.8 | 1.52 | 97.4 | 11.3 | 74.8 | 1.9 | 65.5 |
20% + SA | 10.5 | 213.8 | 2.9 | 334.1 | 10.5 | 233.8 | 2.86 | 183.3 | 11.6 | 76.8 | 1.9 | 65.5 |
50% + SA | 9.1 | 84.5 | 2.1 | 247.6 | 9.0 | 200.4 | 3.42 | 219.2 | 11.4 | 75.5 | 2.6 | 89.7 |
70% + SA | 11.1 | 225.9 | 2.9 | 335.3 | 9.9 | 220.5 | 3.79 | 242.9 | 11.9 | 79.1 | 2.6 | 89.7 |
100% + SA | 4.9 | 100 | 0.856 | 100 | 8.4 | 187.1 | 1.83 | 117.3 | 12.5 | 82.8 | 2.7 | 93.1 |
L. S. D. 0.05% | 0.95 | 1.20 | 0.95 | 0.87 | 0.65 | 0.88 |